Table of Contents Author Guidelines Submit a Manuscript
Journal of Toxicology
Volume 2014, Article ID 917608, 7 pages
http://dx.doi.org/10.1155/2014/917608
Research Article

Camel Milk Beneficial Effects on Treating Gentamicin Induced Alterations in Rats

1Department of Research Center, Prince Sultan Military Medical City, P.O. Box 7897 (775-S), Riyadh 11159, Saudi Arabia
2Department of Urology, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia
3Department of Surgery, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia
4Department of F & C Medicine, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia
5Department of Dentistry, Prince Sultan Military Medical City, P.O. Box 7897, Riyadh 11159, Saudi Arabia

Received 18 May 2014; Revised 10 November 2014; Accepted 10 November 2014; Published 3 December 2014

Academic Editor: Margaret James

Copyright © 2014 Abdulrahman K. Al-Asmari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E.-R. M. Redwan and A. Tabll, “Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes,” Journal of Immunoassay and Immunochemistry, vol. 28, no. 3, pp. 267–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Saltanat, H. Li, Y. Xu, J. Wang, F. Liu, and X.-H. Geng, “The influences of camel milk on the immune response of chronic hepatitis B patients,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 25, no. 5, pp. 431–433, 2009. View at Google Scholar · View at Scopus
  3. T. Althnaian, I. Albokhadaim, and S. M. El-Bahr, “Biochemical and histopathological study in rats intoxicated with carbontetrachloride and treated with camel milk,” SpringerPlus, vol. 2, article 57, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. T. S. Sharmanov, A. K. Zhangabylov, and R. D. Zhaksylykova, “Mechanism of the therapeutic action of whole mare's and camel's milk in chronic hepatitis,” Voprosy pitaniia, vol. 1, pp. 17–23, 1982. View at Google Scholar · View at Scopus
  5. K. H. Knoess, “Milk production of the dromedary,” in Proceeding of the IFS Symposium Camels (SC '79), pp. 201–214, Khartoum, Sudan, 1979.
  6. C. Conesa, L. Sánchez, C. Rota et al., “Isolation of lactoferrin from milk of different species: calorimetric and antimicrobial studies,” Comparative Biochemistry and Physiology—B Biochemistry and Molecular Biology, vol. 150, no. 1, pp. 131–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. H. Omer and A. H. Eltinay, “Changes in chemical composition of camel's raw milk during storage,” Pakistan Journal of Nutrition, vol. 8, no. 5, pp. 607–610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. R. P. Agrawal, S. C. Swami, R. Beniwal, D. K. Kochar, and R. P. Kothari, “Effect of camel milk on glycemic control, risk factors and diabetes quality of life in type-1 diabetes: a randomised prospective controlled study,” International Journal of Diabetes in Developing Countries, vol. 22, no. 2, pp. 70–74, 2002. View at Google Scholar · View at Scopus
  9. R. P. Agrawal, S. Budania, P. Sharma et al., “Zero prevalence of diabetes in camel milk consuming Raica community of north-west Rajasthan, India,” Diabetes Research and Clinical Practice, vol. 76, no. 2, pp. 290–296, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Mohamad, Z. K. Zekry, H. A. Al-Mehdar et al., “Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice,” Journal of Medicinal Food, vol. 12, no. 2, pp. 461–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Rao, R. C. Gupta, and N. N. Dastur, “Camels' milk and milk products,” Indian Journal of Dairy Science, vol. 23, pp. 71–78, 1970. View at Google Scholar
  12. F. Al-Hashem, M. Dallak, N. Bashir et al., “Camel's milk protects against cadmium chloride induced toxicity in white albino rats,” The American Journal of Pharmacology and Toxicology, vol. 4, no. 3, pp. 107–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Al-Hashem, “Camel's milk protects against aluminum chloride-induced normocytic normocromic anemia, lipid peroxidation and oxidative stress in erythrocytes of white albino rats,” American Journal of Biochemistry and Biotechnology, vol. 5, no. 3, pp. 127–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Dallak, “Camel's milk protects against cadmium chloride-induced hypocromic microcytic anemia and oxidative stress in red blood cells of white albino rats,” American Journal of Pharmacology and Toxicology, vol. 4, no. 4, pp. 136–143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. M. Afifi, “Effect of camel’s milk on cisplatin-induced nephrotoxicity in Swiss Albino mice,” The American Journal of Biochemistry and Biotechnology, vol. 6, pp. 141–147, 2010. View at Google Scholar
  16. K. G. Al-Fartosi, O. S. Khuon, and I. Al-Tae, “Protective role of camel's milk against paracetamol induced hepatotoxicity in male rats,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 2, no. 4, pp. 1795–1799, 2011. View at Google Scholar
  17. A. A. Khan and M. Al-zohairy, “Hepatoprotective effects of camel milk against CCl4-induced hepatotoxicity in rats,” Asian Journal of Biochemistry, vol. 6, no. 2, pp. 171–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Ho and M. Barza, “Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 4, pp. 485–491, 1987. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Cuzzocrea, E. Mazzon, L. Dugo et al., “A role for superoxide in gentamicin-mediated nephropathy in rats,” European Journal of Pharmacology, vol. 450, no. 1, pp. 67–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. H. D. Humes, “Aminoglycoside nephrotoxicity,” Kidney International, vol. 33, no. 4, pp. 900–911, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Pedraza-Chaverrí, A. E. González-Orozco, P. D. Maldonado, D. Barrera, O. N. Medina-Campos, and R. Hernández-Pando, “Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats,” European Journal of Pharmacology, vol. 473, no. 1, pp. 71–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  23. W. H. Habig, M. J. Pabst, and W. B. Jakoby, “Glutathione S-transferases. The first enzymatic step in mercapturic acid formation,” The Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130–7139, 1974. View at Google Scholar · View at Scopus
  24. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry, vol. 47, no. 3, pp. 469–474, 1974. View at Publisher · View at Google Scholar · View at Scopus
  25. F. C. Barone, L. M. Hillegass, W. J. Price et al., “Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification,” Journal of Neuroscience Research, vol. 29, no. 3, pp. 336–345, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. I. Khan, M. A. Islam, M. S. Hossain, M. Asadujjaman, M. I. I. Wahed, and B. M. Rahman, “Antidiabetic effects of the different fractions of ethanolic extracts of Ocimum sanctum in normal and alloxan induced diabetic rats,” Journal of Scientific Research, vol. 2, no. 1, pp. 158–168, 2010. View at Google Scholar
  27. A. A. Noorani, K. A. Gupta, K. Bhadada, and M. K. Kale, “Protective effect of methanolic leaf extract of Caesalpinia bonduc (L.) on gentamicin-induced hepatotoxicity and nephrotoxicity in rats,” Iranian Journal of Pharmacology and Therapeutics, vol. 10, no. 1, pp. 21–25, 2011. View at Google Scholar · View at Scopus
  28. A. O. Ademiluyi, G. Oboh, T. R. Owoloye, and O. J. Agbebi, “Modulatory effects of dietary inclusion of garlic (Allium sativum) on gentamycin-induced hepatotoxicity and oxidative stress in rats,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 6, pp. 470–475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Nakajima, A. Hishida, and A. Kato, “Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats,” The American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 266, no. 3, pp. F425–F431, 1994. View at Google Scholar · View at Scopus
  30. L. Y. Al-Ayadhi and N. E. Elamin, “Camel milk as a potential therapy as an antioxidant in autism spectrum disorder (ASD),” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 602834, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. J. Klemens, R. P. Meech, L. F. Hughes, S. Somani, and K. C. M. Campbell, “Antioxidant enzyme levels inversely covary with hearing loss after amikacin treatment,” Journal of the American Academy of Audiology, vol. 14, no. 3, pp. 134–143, 2003. View at Google Scholar · View at Scopus
  32. E. B. Kurutas, A. Cetinkaya, E. Bulbuloglu, and B. Kantarceken, “Effects of antioxidant therapy on leukocyte myeloperoxidase and Cu/Zn-superoxide dismutase and plasma malondialdehyde levels in experimental colitis,” Mediators of Inflammation, vol. 2005, no. 6, pp. 390–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Yaman and E. Balikci, “Protective effects of nigella sativa against gentamicin-induced nephrotoxicity in rats,” Experimental and Toxicologic Pathology, vol. 62, no. 2, pp. 183–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. I. Thabrew, P. D. T. M. Joice, and W. Rajatissa, “A comparative study of the efficacy of Pavetta indica and Osbeckia octandra in the treatment of liver dysfunction,” Planta Medica, vol. 53, no. 3, pp. 239–241, 1987. View at Publisher · View at Google Scholar · View at Scopus
  35. E. M. Hamad, E. A. Abdel-Rahim, and E. A. Romeih, “Beneficial effect of camel milk on liver and kidneys function in diabetic sprague-dawley rats,” International Journal of Dairy Science, vol. 6, no. 3, pp. 190–197, 2011. View at Google Scholar
  36. K. G. Al-Fartosi, A. Majid, M. A. Auda et al., “The role of camel’s milk against some oxidant-antioxidant markers of male rats treated with CCl4,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 3, no. 1, pp. 385–389, 2012. View at Google Scholar
  37. M. T. Boroushaki, E. Asadpour, H. R. Sadeghnia, and K. Dolati, “Effect of pomegranate seed oil against gentamicin-induced nephrotoxicity in rat,” Journal of Food Science and Technology, vol. 51, no. 11, pp. 3510–3514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Yagil, Camel Milk and Autoimmune Diseases: Historical Medicine, 2004.
  39. H. E. Mohamed, H. M. Mousa, and A. C. Beynen, “Ascorbic acid concentrations in milk from Sudanese camels,” Journal of Animal Physiology and Animal Nutrition, vol. 89, no. 1-2, pp. 35–37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Zafra, S. Fraile, C. Gutiérrez et al., “Monitoring biodegradative enzymes with nanobodies raised in Camelus dromedarius with mixtures of catabolic proteins,” Environmental Microbiology, vol. 13, no. 4, pp. 960–974, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Shabo and R. Yagil, “Etiology of autism and camel milk as therapy,” The Journal of Endocrine Genetics, vol. 4, no. 2, pp. 67–70, 2005. View at Google Scholar · View at Scopus
  42. A. I. Al-Humaid, H. M. Mousa, R. A. El-Mergawi, and A. M. Abdel-Salam, “Chemical composition and antioxidant activity of dates and dates-camel-milk mixtures as a protective meal against lipid peroxidation in rats,” American Journal of Food Technology, vol. 5, no. 1, pp. 22–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Rose, S. Melnyk, O. Pavliv et al., “Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain,” Translational Psychiatry, vol. 2, article e134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. R. M. Nagra, B. Becher, W. W. Tourtellotte et al., “Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis,” Journal of Neuroimmunology, vol. 78, no. 1-2, pp. 97–107, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. P. S. Green, A. J. Mendez, J. S. Jacob et al., “Neuronal expression of myeloperoxidase is increased in Alzheimer's disease,” Journal of Neurochemistry, vol. 90, no. 3, pp. 724–733, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. K. Anthony, J. Russo, B. Jepson, and A. Wakefield, “Low serum myeloperoxidase in autistic children with gastrointestinal disease,” Journal of Clinical and Experimental Gastroenterology, vol. 2, no. 2, pp. 85–94, 2009. View at Publisher · View at Google Scholar
  47. N. A. Meguid, A. A. Dardir, E. R. Abdel-Raouf, and A. Hashish, “Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation,” Biological Trace Element Research, vol. 143, no. 1, pp. 58–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Barbagallo, L. J. Dominguez, M. R. Tagliamonte, L. M. Resnick, and G. Paolisso, “Effects of vitamin E and glutathione on glucose metabolism: role of magnesium,” Hypertension, vol. 34, no. 4, pp. 1002–1006, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Virginia, M. B. Smith, M. J. Brauner, and M. P. Majerus, “Glutathione synthesis in human erythrocytes,” The Journal of Clinical Investigation, vol. 50, pp. 507–513, 1971. View at Google Scholar
  50. C. Yanagida, K. Ito, I. Komiya, and T. Horie, “Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue,” Chemico-Biological Interactions, vol. 148, no. 3, pp. 139–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. P. D. Maldonado, D. Barrera, I. Rivero et al., “Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage,” Free Radical Biology and Medicine, vol. 35, no. 3, pp. 317–324, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. O. U. Beg, H. Von Bahr-Lindstrom, Z. H. Zaidi, and H. Jornvall, “A camel milk whey protein rich in half-cystine. Primary structure, assessment of variations, internal repeat patterns, and relationships with neurophysin and other active polypeptides,” European Journal of Biochemistry, vol. 159, no. 1, pp. 195–201, 1986. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Martin, C. Volpari, C. Steinkühler et al., “Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease,” Protein Engineering, vol. 10, no. 5, pp. 607–614, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. O. U. Beg, H. Von Bahr-Lindstrom, Z. H. Zaidi, and H. Jornvall, “Characterization of a camel milk protein rich in proline identifies a new β-casein fragment,” Regulatory Peptides, vol. 15, no. 1, pp. 55–62, 1986. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Yagil, “Camel milk—a review,” International Journal of Animal Sciences, vol. 2, pp. 81–89, 1987. View at Google Scholar
  56. E. K. Barbour, N. H. Nabbut, W. M. Ferisch, and H. M. Ai-Nakhli, “Inhibition of pathogenic bacteria by camels milk: relation to whey lysozyme and stage of lactation,” Journal of Food Protection, vol. 47, pp. 838–840, 1984. View at Google Scholar
  57. E. I. El Agamy, R. Ruppanner, A. Ismail, C. P. Champagne, and R. Assaf, “Antibacterial and antiviral activity of camel milk protective proteins,” Journal of Dairy Research, vol. 59, no. 2, pp. 169–175, 1992. View at Publisher · View at Google Scholar · View at Scopus
  58. M. T. El-Mougi, Basic Pediatrics, Faculty of Medicine, Al-Azher University, Cairo, Egypt, 1999.
  59. E. Y. Mona, O. M. Ragia, A. K. H. Abeer, and T. E. Mosa, “Biochemical effects of fermented camel milk on diarrhea in rats,” New York Science Journal, vol. 3, no. 5, pp. 106–111, 2010. View at Google Scholar
  60. E. M. Hamad, E. A. Abdel-Rahim, and E. A. Romeih, “Beneficial effect of camel milk on liver and kidneys function in diabetic Sprague-Dawley rats,” International Journal of Dairy Science, vol. 6, no. 3, pp. 190–197, 2011. View at Google Scholar
  61. H. Tsuda and T. Miyamoto, “Angiotensin I-converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China,” Journal of the Science of Food and Agriculture, vol. 88, no. 15, pp. 2688–2692, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. A. A. Elayan, A. M. E. Sulieman, and F. A. Saleh, “The hypocholesterolemic effect of Gariss and Gariss containing bifidobacteria in rats fed on a cholesterol-enriched diet,” Asian Journal of Biochemistry, vol. 3, no. 1, pp. 43–47, 2008. View at Publisher · View at Google Scholar · View at Scopus